Dr. Riaz Elahi, MD

Dr. Elahi practices at Advocate Medical Group Outpatient Center - Orland Park in Orland Park, Illinois.

Dr. Elahi's NPI, 1356421325, was assigned on October 16, 2006. Dr. Elahi holds Illinois license 036072826.

Dr. Elahi's primary practice is Advocate Medical Group Outpatient Center - Orland Park, at 9550 West 167th St, Orland Park, IL 60467.

Dr. Elahi's primary practice is Advocate Medical Group Outpatient Center - Orland Park in Orland Park, Illinois. Dr. Elahi is also affiliated with Advocate Christ Medical Center. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Elahi to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Elahi's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elahi practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Elahi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Elahi is licensed in Illinois.

CMS data shows 785 Medicare services from Dr. Elahi across 8 procedure codes in 2024, for 295 Medicare patients. Medicare paid $59,349 for them.

CMS counts 295 Medicare patients who saw Dr. Elahi in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elahi's median patient age at 75, with 61% women.

In 2024, Dr. Elahi wrote 473 Medicare Part D claims for 97 patients. 67% of them were for generic drugs. CMS names the drug for 357 of them, across 13 drugs with 11 or more claims each, at $395,527 in total drug cost. In 2023, CMS named 549 claims across 19 drugs.

Dr. Elahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elahi as offering telehealth.

Dmand AI links Dr. Elahi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Male and Breast Neoplasms.

CMS Open Payments shows 46 general payments to Dr. Elahi from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Genentech, Inc. paid the most, $138.